Tremeau Pharmaceuticals
Pre-clinicalLeading the way for those left behind in pain by focusing on providing non-opioid pain therapies for patients in need.
Founded
2016
Focus
Small Molecules
About
Leading the way for those left behind in pain by focusing on providing non-opioid pain therapies for patients in need.
Funding History
2Total raised: $95M
Series B$70MF-Prime CapitalJun 15, 2020
Series A$25MF-Prime CapitalJun 15, 2017
Company Info
TypePrivate
Founded2016
LocationConcord, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile